Validity and feasibility of the self-report EQ-5D-Y as a generic Health-Related Quality of Life outcome measure in children and adolescents with Juvenile Idiopathic Arthritis in Western Cape, South Africa

dc.contributor.authorScott, Desireeen_ZA
dc.contributor.authorScott, Christiaanen_ZA
dc.contributor.authorJelsma, Jenniferen_ZA
dc.contributor.authorVerstraete, Janineen_ZA
dc.contributor.authorAbraham, Deepthien_ZA
dc.date.accessioned2021-03-16T10:08:34Z
dc.date.available2021-03-16T10:08:34Z
dc.date.issued2019
dc.descriptionCITATION: Scott, D., et al. 2019. Validity and feasibility of the self-report EQ-5D-Y as a generic Health-Related Quality of Life outcome measure in children and adolescents with Juvenile Idiopathic Arthritis in Western Cape, South Africa. South African Journal of Physiotherapy, 75(1):a1335, doi:10.4102/sajp.v75i1.1335.
dc.descriptionThe original publication is available at http://www.sajp.co.za
dc.description.abstractBackground: Health-Related Quality of Life (HRQoL) data together with clinical findings allow for monitoring of intervention efficacy and the effect on HRQoL. Children with Juvenile Idiopathic Arthritis (JIA) experience symptoms often persisting into adulthood, emphasising the need to track HRQoL. Objectives: The aim of this study was to investigate psychometric properties of the EuroQol five-dimensional youth questionnaire (EQ-5D-Y) in children with JIA. Methods: A cross-sectional, analytical study design was used. Children 8 to 15 years were recruited, completing the self-report EQ-5D-Y and two other HRQoL questionnaires. Known group validity was established by comparing the effect size between children with different disease severities. Concurrent validity was tested using Kruskal–Wallis to compare the ranking of scores on different questionnaires. Feasibility was assessed by number of missing responses and time to complete each questionnaire. Results: All questionnaires were able to distinguish between children with different JIA severity. There was a significant difference in ranking of most Juvenile Arthritis Multidimensional Assessment Report dimension scores across EQ-5D-Y levels, (p < 0.05), indicating concurrent validity. There was poor concurrent validity with the PedsQL dimensions tested with EQ-5D-Y, except for ‘pain’ (p = 0.001). The EQ-5D-Y was the quickest to complete with no missing values. Conclusion: This study showed that the EQ-5D-Y is valid and feasible in measuring HRQoL in JIA children and adequately responsive to detect change over time. Clinical implications: It is quick and easy to use in a busy clinical setting, allowing for effective JIA management monitoring.en_ZA
dc.description.urihttps://sajp.co.za/index.php/sajp/article/view/1335
dc.description.versionPublisher's version
dc.format.extent9 pagesen_ZA
dc.identifier.citationScott, D., et al. 2019. Validity and feasibility of the self-report EQ-5D-Y as a generic Health-Related Quality of Life outcome measure in children and adolescents with Juvenile Idiopathic Arthritis in Western Cape, South Africa. South African Journal of Physiotherapy, 75(1):a1335, doi:10.4102/sajp.v75i1.1335
dc.identifier.issn2410-8219 (online)
dc.identifier.issn0379-6175 (print)
dc.identifier.otherdoi:10.4102/sajp.v75i1.1335
dc.identifier.urihttp://hdl.handle.net/10019.1/109664
dc.language.isoen_ZAen_ZA
dc.publisherAOSISen_ZA
dc.rights.holderAuthors retain copyrighten_ZA
dc.subjectAutoimmune diseases -- Childrenen_ZA
dc.subjectJuvenile Idiopathic Arthritisen_ZA
dc.subjectQuality of life -- Health aspectsen_ZA
dc.titleValidity and feasibility of the self-report EQ-5D-Y as a generic Health-Related Quality of Life outcome measure in children and adolescents with Juvenile Idiopathic Arthritis in Western Cape, South Africaen_ZA
dc.typeArticleen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
scott_validity_2021.pdf
Size:
682.3 KB
Format:
Adobe Portable Document Format
Description:
Download article
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: